Found: 4
Select item for more details and to access through your institution.
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*.
- Published in:
- British Journal of Dermatology, 2021, v. 185, n. 5, p. 1035, doi. 10.1111/bjd.20588
- By:
- Publication type:
- Article
CLONAL B‐CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL‐MZ): DESCRIPTION OF MAIN CLINICAL FEATURES, DISEASE EVOLUTION AND OUTCOME IN A SERIES OF 100 PATIENTS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 223, doi. 10.1002/hon.38_2630
- By:
- Publication type:
- Article
CLONAL B‐CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL‐MZ): DESCRIPTION OF MAIN CLINICAL FEATURES, DISEASE EVOLUTION AND OUTCOME IN A SERIES OF 100 PATIENTS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 223, doi. 10.1002/hon.38_2630
- By:
- Publication type:
- Article
Brentuximab induced CD30<sup>+</sup> cutaneous lymphoma responded to anti‐PD1 treatment.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor